Cargando…
Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
BACKGROUND: Alopecia areata (AA) is an autoimmune skin disease difficult to manage and treat. The pathogenesis of AA features a T-cell-associated autoimmune process, and systemic immunosuppressive therapy is prescribed widely for AA. OBJECTIVE: To evaluate the efficacy and tolerance of systemic low-...
Autores principales: | Lim, Seul-Ki, Lim, Cho-Ah, Kwon, In Sun, Im, Myung, Seo, Young-Joon, Kim, Chang-Deok, Lee, Jeung-Hoon, Lee, Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438930/ https://www.ncbi.nlm.nih.gov/pubmed/28566900 http://dx.doi.org/10.5021/ad.2017.29.3.263 |
Ejemplares similares
-
Extensive Alopecia Areata: Not Necessarily Recalcitrant to Therapy!
por: Deshpande, Deepal, et al.
Publicado: (2011) -
Congenital Lipedematous Alopecia: Adding to the Differential Diagnosis of Congenital Alopecia
por: Lee, Hae-Eul, et al.
Publicado: (2015) -
Clinical Relevance for Serum Cold-Inducible RNA-Binding Protein Level in Alopecia Areata
por: Shin, Jung-Min, et al.
Publicado: (2019) -
Efficacy and safety of methotrexate in alopecia areata
por: Hammerschmidt, Mariana, et al.
Publicado: (2014) -
Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
por: Choi, Joong-Woon, et al.
Publicado: (2017)